FNY Managed Accounts’s Synergy Pharmaceuticals SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1K Hold
1,000
– – ﹤0.01% 574
2017
Q4
$2K Sell
1,000
-5,400
-84% -$13.4K ﹤0.01% 539
2017
Q3
$18K Buy
+6,400
New +$21.8K 0.02% 364
2015
Q2
– Sell
-2,500
Closed -$11.6K – 639
2015
Q1
$11.6K Buy
+2,500
New +$8.13K 0.01% 240

Other funds holding SGYP

FNY Managed Accounts's SGYP Position: Q1 2018 in Review

FNY Managed Accounts held its Synergy Pharmaceuticals (SGYP) position steady in Q1 2018 at 1,000 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

FNY Managed Accounts first reported a position in SGYP in Q1 2015 and has held it in 4 quarters since. The position peaked at $18K in Q3 2017. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

  • FNY Managed Accounts held 1,000 shares of Synergy Pharmaceuticals worth $1K as of Q1 2018.
  • FNY Managed Accounts left its Synergy Pharmaceuticals share count unchanged in Q1 2018.
  • Synergy Pharmaceuticals made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #574 holding.
  • FNY Managed Accounts first reported a position in Synergy Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
  • FNY Managed Accounts's Synergy Pharmaceuticals position peaked at $18K in Q3 2017.
  • 147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.